Get a proposal

Clinical trial expertise

Indications we run clinical trials in

Evidence briefs for every indication — the approved therapies and their pivotal-trial endpoints, the magnitude of benefit, and the drugs that failed and why. A physician-led view of where each field stands.

Oncology

Oncology indications

Colorectal Cancer

ICD-10 C18.9 · approved drugs, endpoints & failures.

View →

Cervical Cancer

ICD-10 C53.9 · approved drugs, endpoints & failures.

View →

Endometrial (Uterine) Cancer

ICD-10 C54.1 · approved drugs, endpoints & failures.

View →

Head & Neck Cancer (SCCHN)

ICD-10 C76.0 · approved drugs, endpoints & failures.

View →

Oesophageal Cancer

ICD-10 C15.9 · approved drugs, endpoints & failures.

View →

Hepatocellular Carcinoma

ICD-10 C22.0 · approved drugs, endpoints & failures.

View →

Renal Cell Carcinoma

ICD-10 C64.9 · approved drugs, endpoints & failures.

View →

Testicular Cancer

ICD-10 C62.90 · approved drugs, endpoints & failures.

View →

Small-Cell Lung Cancer

ICD-10 C34.90 · approved drugs, endpoints & failures.

View →

Non-Small-Cell Lung Cancer

ICD-10 C34.90 · approved drugs, endpoints & failures.

View →

Cholangiocarcinoma

ICD-10 C22.1 · approved drugs, endpoints & failures.

View →

Anal Cancer

ICD-10 C21.0 · approved drugs, endpoints & failures.

View →

Vulvar Cancer

ICD-10 C51.9 · approved drugs, endpoints & failures.

View →

Mesothelioma

ICD-10 C45.9 · approved drugs, endpoints & failures.

View →

Neuroendocrine Tumours

ICD-10 C7A.00 · approved drugs, endpoints & failures.

View →

Gastrointestinal Stromal Tumour (GIST)

ICD-10 C49.A0 · approved drugs, endpoints & failures.

View →

Soft-Tissue Sarcoma

ICD-10 C49.9 · approved drugs, endpoints & failures.

View →

Osteosarcoma

ICD-10 C41.9 · approved drugs, endpoints & failures.

View →

Ewing Sarcoma

ICD-10 C41.9 · approved drugs, endpoints & failures.

View →

Basal Cell Carcinoma

ICD-10 C44.91 · approved drugs, endpoints & failures.

View →

Cutaneous Squamous Cell Carcinoma

ICD-10 C44.92 · approved drugs, endpoints & failures.

View →

Merkel Cell Carcinoma

ICD-10 C4A.9 · approved drugs, endpoints & failures.

View →

Nasopharyngeal Carcinoma

ICD-10 C11.9 · approved drugs, endpoints & failures.

View →

Neuroblastoma

ICD-10 C74.90 · approved drugs, endpoints & failures.

View →

Medulloblastoma

ICD-10 C71.6 · approved drugs, endpoints & failures.

View →

Don't see your indication?

We run trials across every therapeutic area. Tell us about your programme and we'll scope it.

Request a proposal